Marc Rubin

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Francisco, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Diantha Duvall, Attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Marc Rubin

Form 4 holding Director

CURIS INC

Security class
Non Qualified Stock Option
Shares / value
6,800
Estimated value
$45,072
Report date
07 Jul 2026
Price
$3.13
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CURIS INC

Security class
Common Stock
Shares / value
28,108
Estimated value
$31,199
Report date
20 Mar 2026
Price
$1.11
Ownership
Direct
Form 4 holding Executive Chairman, Director

TITAN PHARMACEUTICALS INC

Security class
Option to Purchase Common Stock
Shares / value
65,000
Estimated value
Report date
05 Jan 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

GALECTIN THERAPEUTICS INC

Security class
Stock Option (right to buy)
Shares / value
60,000
Estimated value
Report date
23 Jan 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CURIS INC

Security class
Series A Warrant (right to buy)
Shares / value
26,667
Estimated value
Report date
17 Mar 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CURIS INC

Security class
Series B Warrant (right to buy)
Shares / value
26,667
Estimated value
Report date
17 Mar 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CURIS INC

Security class
Series C Warrant (right to buy)
Shares / value
26,667
Estimated value
Report date
17 Mar 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CURIS INC

Security class
Series B Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
20 Mar 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Marc Rubin

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .